Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
about
Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend?Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low- and middle-income countries: a systematic review.Understanding Toxoplasmosis in the United States Through "Large Data" AnalysesTrends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil.Consistent ART adherence is associated with improved quality of Life, CD4 counts, and reduced hospital costs in central China.An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults.Enhancing psychosocial support for HIV positive adolescents in Harare, Zimbabwe.HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort.Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected childrenTrends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda.IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression.Use of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii.Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease.Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): DesignMolecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.Concurrent PCP and TB pneumonia in HIV infected patients.Clinical review: Respiratory failure in HIV-infected patients--a changing picture.Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.Difficulties with diagnosis and consequential poor outcome due to stigma of acquired immunodeficiency syndrome - a case report.Cognitive interviewing for cross-cultural adaptation of pediatric antiretroviral therapy adherence measurement items.A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?Immune suppression of JC virus gene expression is mediated by SRSF1.Evaluation of sensitivity of multiplex PCR for Detection of Mycobacterium tuberculosis and Pneumocystis jirovecii in clinical samples.Evaluating a multi-component, community-based program to improve adherence and retention in care among adolescents living with HIV in Zimbabwe: study protocol for a cluster randomized controlled trial.Neuroimmune Regulation of JC Virus by Intracellular and Extracellular Agnoprotein.A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child: A case report and literature review.Factors sustaining pediatric adherence to antiretroviral therapy in western Kenya.Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa.Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART).Progressive multifocal leukoencephalopathy as an AIDS-defining condition in a patient with high CD4+ T-lymphocyte count.
P2860
Q26752860-59C5F055-B1A6-459B-A753-78586500A839Q30371970-1C1450D0-61A6-478A-8D4A-76B755265371Q31111181-8968C775-71A7-49A3-84CC-314CD0525164Q33717183-8E639B8B-4152-44BA-959D-83CE30448D95Q33807634-87273105-6566-462F-BB94-CCE4ACF6F075Q33917623-7A937E05-CB1B-4F11-9B86-B55C62D01BBEQ34875901-DC7CC834-20BF-42A6-B365-013575B82938Q35149265-BB13D1B4-7E5C-41D3-9EC9-7EC2FEDC1BF9Q35371115-921ED8CD-61E0-489B-9A1A-7759D1727801Q35534405-8331DA7F-E5E4-45D6-BFCA-2456458F428BQ35659985-1164A7A6-E989-4323-8DE9-02D931D62F04Q35837803-5EA2ECAE-285D-4384-B55B-FA675CFA3F05Q35917465-7BDC3668-7CC9-48AA-80F6-3C7D04FE7B95Q35959278-032AAEDC-3897-41DE-B806-89760C9D45B0Q35973095-9CF7F676-3CF5-4FF2-8E42-7B01B3F0EAFDQ36310748-C1AC9106-A7DC-4942-894F-6A94679BE544Q36530478-0829983A-9368-4077-8A9B-C1494639B079Q36939689-703A4D97-AD5B-4FC7-9C9F-E4CD27E4D016Q36998358-076DB9B4-0579-472A-B610-4FCBA1CE72A2Q37713756-2E44EBFA-A652-4382-9648-224C56B8AA94Q37726827-43E3EB76-D7EB-4C46-AEF5-A73E22A1844BQ38063174-B993519E-BBB4-4C48-825B-B44AA65A7A40Q38879927-F36E9E5C-349A-47A8-BACA-3F49548E24FAQ40764534-6BC1CB95-F0D8-4233-A0AE-767D2AB2E65CQ42428196-62AD4875-69B0-4EB2-B3A5-C6F27C5A0878Q42668987-BCE7E6D6-6872-4679-AC98-85B0F120EFE7Q45324517-3F8D35AE-27B3-458B-8076-BCFCC264FC6FQ47142358-3308E7BB-1E24-4083-B227-1A2E51EF41F0Q47424214-E56FFD97-B52E-434E-AFE4-3A55BAC5DBF2Q50025133-86290A49-75C8-4229-AEED-237512D40524Q51040063-23186A87-46F9-46BE-B01C-C14CDAB2C4B8Q53242999-5BDA84E1-0DA9-4937-868E-9FF20C9EF962
P2860
Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Incidence of acquired immunode ...... nodeficiency virus, 1989-1997.
@en
Incidence of acquired immunode ...... nodeficiency virus, 1989-1997.
@nl
type
label
Incidence of acquired immunode ...... nodeficiency virus, 1989-1997.
@en
Incidence of acquired immunode ...... nodeficiency virus, 1989-1997.
@nl
prefLabel
Incidence of acquired immunode ...... nodeficiency virus, 1989-1997.
@en
Incidence of acquired immunode ...... nodeficiency virus, 1989-1997.
@nl
P2093
P2860
P356
P1476
Incidence of acquired immunode ...... nodeficiency virus, 1989-1997.
@en
P2093
Angel del Palacio
Francisco-Javier San-Andrés
Guillermo Palao
Inmaculada de Pedro
Jesús Castilla
José-Ramón Costa
Rafael Rubio
P2860
P304
P356
10.1086/374358
P407
P577
2003-04-14T00:00:00Z